Publisher & Media Owner · vs · B2C Consumer App / Platform
WebMD vs Weedmaps
Structured technology and market comparison · 2026
Direct Feature Comparison
WebMD · vs · WeedmapsDigital health publisher with healthcare advertising and audience targeting assets.
Cannabis marketplace and SaaS advertising platform for dispensaries and brands.
Analyze all overlapping signals and tech stacks for WebMD and Weedmaps
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between WebMD and Weedmaps?
When comparing WebMD and Weedmaps, both platforms operate within the Self-Serve Ad Platform, In-App, and Native & Contextual Ads ecosystem. WebMD is positioned as Digital health publisher with healthcare advertising and audience targeting assets, whereas Weedmaps focuses on Cannabis marketplace and SaaS advertising platform for dispensaries and brands. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to WebMD and Weedmaps?
When evaluating WebMD and Weedmaps, enterprise buyers also consider other platforms in Self-Serve Ad Platform, In-App, and Native & Contextual Ads. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
Market Signals
Recent Market Signals & Activity: WebMD vs Weedmaps
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
WebMD
Recent Signals
No recent market signals documented for WebMD in the current tracking window.
Weedmaps
Recent Signals
- ·SEC APIfinancials
10-Q Financial Filing Analysis for Weedmaps (2026-08-06)
WM Technology, Inc. (Weedmaps) reported its Q2 2026 financial results, generating $42.45 million in revenue, a 5% decrease year-over-year from $44.85 million in Q2 2025. Net income improved to $2.88 million compared to $2.16 million in the prior-year period, primarily driven by a 7% reduction in total operating expenses to $40.09 million and the partial reversal of AWS purchase commitment loss contingencies. However, Adjusted EBITDA declined sharply by 58% to $4.97 million compared to $11.73 million in Q2 2025. Operationally, the company continues to face headwinds in its core California market and established regions due to customer margin compression, industry consolidation, and price deflation. Average monthly paying clients fell 4% YoY to 5,040, and average monthly revenue per paying client slipped to $2,807. During the quarter, the company completed its voluntary delisting from Nasdaq to the OTCQX market and settled major putative shareholder and derivative class actions for $7.5 million (mostly insurance-funded).
- Q2 2026 revenue fell 5.4% YoY to $42.45 million, while net income rose to $2.88 million ($0.02 EPS) and Adjusted EBITDA dropped 57.6% YoY to $4.97 million.
- Average monthly paying clients dropped 4% YoY to 5,040 with average monthly revenue per paying client decreasing to $2,807.
- Completed voluntary delisting from Nasdaq on April 24, 2026, transitioning trading of Class A Common Stock to the OTCQX Best Market under ticker MAPS.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners WebMD and Weedmaps share across the market ecosystem.